XML 42 R24.htm IDEA: XBRL DOCUMENT
v3.20.4

Other income | 12 Months Ended
--- | ---
Dec. 31, 2020
Other income | NOTE 16—Other income:
|  | Year ended December 31, |
|  | 2020 |  |  | 2019 |  |  | 2018 |
|  | (U.S. $ in millions) |
Gain on divestitures, net of divestitures related costs (1) |  | $ | 8 |  |  |  | 50 |  |  |  | 67 |
Section 8 and similar payments (2) |  |  | — |  |  |  | 5 |  |  |  | 195 |
Gain (loss) on sale of assets |  |  | 11 |  |  |  | (1 | ) |  |  | 9 |
Other, net |  |  | 20 |  |  |  | 22 |  |  |  | 20 |
Total other income |  | $ | 40 |  |  | $ | 76 |  |  | $ | 291 |
(1) | Mainly related to the divestment of several activities in the International Markets segment.
(2) | Section 8 of the Patented Medicines (Notice of Compliance) Regulation relates to recoveries of lost revenue related to patent infringement proceedings in Canada.

X
- Definition The entire disclosure for other operating income and other operating expense items. + References No definition available. + Details
Name: | us-gaap_OtherOperatingIncomeAndExpenseTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration